Tag: Cognitive decline

According to the American Geriatrics Society, the antihistamine diphenhydramine—a key ingredient in Tylenol PM—is listed as a potentially inappropriate medication for older adults. This is because the aging body is more susceptible to the drug's sedative and anticholinergic side effects, which can lead to significant health complications and make it clear why people over 65 should not take Tylenol PM.

The American Geriatrics Society (AGS) Beers Criteria explicitly lists benzodiazepines, including lorazepam, as potentially inappropriate medications for older adults due to their significant risks. For elderly patients, understanding why is lorazepam not good for the elderly is crucial for safe medication management and improved health outcomes.

An estimated 7.2 million Americans age 65 and older are living with Alzheimer's in 2025 [1.7.2]. This staggering number fuels the urgent search for effective treatments, leading many to ask: What is the miracle drug for Alzheimer's?

Despite a common misconception, clinical evidence confirms that medications like **rivastigmine**, a cholinesterase inhibitor, do not cure or stop the progression of Alzheimer’s and other forms of dementia. Its primary role is to manage symptoms and improve a patient’s quality of life for a period.

Over 6 million Americans are affected by Alzheimer's disease, a leading cause of cognitive decline. Recent advances have led to FDA approval of new medications for cognitive decline, including Leqembi (lecanemab) and Kisunla (donanemab), marking a new era in treatment by targeting the underlying pathology.

Despite decades of limited progress in Alzheimer's disease treatment, the landscape is changing rapidly with recent FDA approvals of disease-modifying therapies. This significant progress has led many to ask what is the new miracle drug for dementia?, though experts caution against using such sensationalist language that misrepresents the modest benefits and real risks involved.

As a first-generation antihistamine, doxylamine is known to cross the blood-brain barrier, directly influencing the central nervous system. This is precisely how it achieves its sedative effects, but it also prompts the question: What does doxylamine do to your brain in detail?

Approximately 1 in 20 people over 60 in the UK have a vitamin B12 deficiency, but its wide-ranging and often subtle symptoms can easily be mistaken for other conditions. Understanding **what can be misdiagnosed as B12 deficiency** is crucial for preventing delayed diagnosis and potential irreversible neurological damage. The overlap of symptoms can lead to misattribution and improper treatment, making accurate diagnosis a challenge for clinicians.

While there is no cure for most progressive dementias, medications can be used to manage symptoms and temporarily slow their worsening. Understanding what drug is used to slow down dementia involves examining different pharmacological classes that target specific brain processes to stabilize cognitive and functional abilities for a period of time.

A 2018 study on antiepileptic drug use found regular use of medications with cognitive adverse effects was associated with a 59% increased risk of incident dementia. Understanding which epilepsy drugs cause dementia is crucial for long-term treatment planning, as various factors influence cognitive outcomes.